Sanofi (SNY) Earnings Analysis

Sanofi (SNY) next reports earnings on 2026-07-30, consensus EPS 1.09 USD. Last quarter (2026-04-23) it beat with EPS 1.1 USD vs 1.06 USD est (+3.8%). It has beaten estimates in 6/8 recent quarters (75%). Trailing P/E 12.27.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does SNY next report earnings?

Next earnings date2026-07-30
Consensus EPS estimate1.09 USD
Revenue estimate12.44B

SNY earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-231.1 USD1.06 USD+3.8%Beat
2026-01-290.89 USD0.84 USD+6%Beat
2025-10-241.7 USD1.6 USD+6.2%Beat
2025-07-310.9 USD0.96 USD-6.2%Miss
2025-04-240.94 USD0.9 USD+4.4%Beat
2025-01-300.7 USD0.71 USD-1.4%Miss
2024-10-251.57 USD1.35 USD+16.3%Beat
2024-07-250.93 USD0.86 USD+8.1%Beat

Beat rate: 6/8 (75%) over reported quarters with consensus data.

SNY valuation and analyst view

Trailing P/E12.27
Trailing EPS3.14 USD
Price / book1.26
Dividend yield5.42%
Market cap105.49B
Analyst consensusHold (12 buy / 14 hold / 1 sell)
Avg price target50.5 USD

Related research pages

Frequently asked questions

When is Sanofi (SNY)'s next earnings date?

Sanofi is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 1.09 USD and revenue estimate of 12.44B.

Did SNY beat earnings last quarter?

In its 2026-04-23 report, SNY posted EPS of 1.1 USD versus a 1.06 USD estimate — a beat of 3.8%.

What is SNY's earnings track record?

Over the last 8 reported quarters with consensus data, SNY beat estimates 6 times (75%).

What is SNY's current P/E ratio and EPS?

SNY trades at a trailing P/E of 12.27 on trailing EPS of 3.14 USD.

What do analysts rate SNY?

Analyst consensus is "Hold" across 27 ratings (0 strong buy, 12 buy, 14 hold, 1 sell, 0 strong sell). Average 12-month price target: 50.5 USD.